Imeglimin is a novel oral medication used to treat type 2 diabetes. It works by improving insulin sensitivity, enhancing glucose utilization, and reducing the production of glucose in the liver. Imeglimin represents a new class of diabetes drugs that target multiple metabolic pathways to manage blood sugar levels.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Imeglimin and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Imeglimin impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Imeglimin-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
